Citations

Showing 10 of 108104 citations.

Asynchronous Education for Graduate Medical Trainees to Reduce Health Disparities and Address Social Determinants of Health
Albold, Cheryll, Balls‐Berry, Joyce E.

Mayo Clinic

Advances in Medical Education, Research, and Ethics | October 31, 2018 | Volume: No volume available | Issue: No issue available | Pages: 1-20

10.4018/978-1-5225-6289-4.ch001 Get It

Health disparities and social determinants of health are directly linked to access, quality of healthcare, and increase in morbidity and mortality in minority and diverse communities. It is accepted that physicians lead healthcare teams; therefore, academic medical centers must assume the responsibility to provide training to reduce health disparities. The nation's academic medical centers and teaching hospitals have a responsibility to provide education on how healthcare disparities impacts diverse patient populations. This chapter provides a detailed overview of the curriculum development process and design of two asynchronous learning modules on health disparities and social determinants of health for graduate medical learners enrolled in multiple clinical specialty areas throughout one academic medical center's three geographic regional campuses. Formative and summative evaluation processes allowed the curriculum design team to revise the module design process, in situ and throughout the creation of the modules as well as evaluate learner growth and satisfaction.
AOFAS Position Statement Regarding Patient-Reported Outcome Measures
Kitaoka, Harold B. , Meeker, James E. , Phisitkul, Phinit, Adams, Samuel B. , Kaplan, Jonathan , Wagner, Emilio

Mayo Clinic

Foot & Ankle International | October 31, 2018 | Volume: 39 | Issue: 12 | Pages: 1389-1393

10.1177/1071100718809066 | PMID 30379085 Get It

Outcome measures evaluate various aspects of patient health, and when appropriately utilized can provide valuable information in both clinical practice and research settings. The orthopedic community has placed increasing emphasis on patient-reported outcome measures, recognizing their value for understanding patients’ perspectives of treatment outcomes. Patient-reported outcomes are information directly reported by patients regarding their perceptions of health, quality of life, or functional status without interpretation by healthcare providers. The American Orthopaedic Foot & Ankle Society (AOFAS) supports the use of validated patient-reported outcome (PRO) instruments to assess patient general health, functional status, and outcomes of treatment. It is not possible to recommend a single instrument to collect quality orthopedic data as the selection is dependent on the population being examined and the question being asked. We support the use of the PROMIS Physical Function Computerized Adaptive Test (PF CAT) or Lower Extremity Computerized Adaptive Test (LE CAT), which can be assessed with other domains such as Pain Interference. In addition, a disease-specific measure can be used when available.
Improved utilization of waist‐to‐height ratio in cardiometabolic risk counselling in children: Application of DMAIC strategy
Gupta, Nidhi , Lteif, Aida, Creo, Ana L. , Iqbal, Anoop Mohamed, Pittock, Siobhán T. , Tebben, Peter J. , Hansen, Janet S., Heyrman, Mary, Spee, Rebecca, Scanlan‐Hanson, Lori N. , Kumar, Seema , Creo, Ana , Pittock, Siobhan , Hansen, Janet, Scanlan-Hanson, Lori, Tebben, Peter , Hansen, Janet

Mayo Clinic

Journal of Evaluation in Clinical Practice | October 31, 2018 | Volume: 25 | Issue: 2 | Pages: 300-305

10.1111/jep.13055 | PMID 30378218 Get It

AbstractRationale, aims, and objectivesWaist circumference (WC) and waist‐to‐height ratio (WHtR) are superior surrogate markers of central obesity than body mass index. However, WC is not measured routinely in paediatric clinics. The objective of this study was to implement measurement of WC during routine assessment of children in an ambulatory outpatient clinic setting and subsequent dissemination of cardiometabolic risk counselling in children with central obesity (defined as WHtR ≥0.5).MethodProspective cohort of patients aged 6 to 20 years. Study period was divided into three phases: baseline (3 months), process improvement (2 months), and implementation (6 months). Define‐Measure‐Analyse‐Improve‐Control (DMAIC) strategy was applied. Measurement of WC was implemented as a component of the physical examination in patients. Outcome measures were (1) improvement in frequency of WC measurement and (2) utilization of WHtR in cardiometabolic risk counselling.ResultsWaist circumference was not measured in any patient during baseline phase (n = 551). During process improvement phase, of the total 347 patients, WC was measured in 35% vs target of 30%. In the implementation phase, WC was measured in 37% patients (365 out of 964). Of these 365 patients, 175 (48%) had elevated WHtR, and 73% of them (n = 128) were counselled about their increased cardiometabolic risk.ConclusionsApplication of an evidence‐based DMAIC protocol led to significant improvement in assessment for central obesity in an ambulatory clinic practice and appropriate counselling regarding cardiometabolic risk reduction in children and adolescents with central obesity over an 8‐month period. Meticulous planning and execution, frequent reinforcement, and integrating feedback from the involved multi‐disciplinary team were important factors in successful implementation of this quality improvement project.
Revising Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project
Tavella, Gabriela , Berk, Michael , Grunze, Heinz , Deckersbach, Thilo , Dünner, David L., Amsterdam, Jay D., Ketter, Terence A. , Yatham, Lakshmi N. , Kessing, Lars Vedel , Bassett, Darryl, Fountoulakis, Kostas N, Duffy, Anne , Alda, Martin , Sharma, Verinder , Singh, Manpreet K. , Hájek, Tomáš , Boyce, Philip , Frey, Benício N. , Castle, David , Young, Allan H. , Vieta, Eduard , Swartz, Holly A. , Schaffer, Ayal , Murray, Greg , Bayes, Adam , Lam, Raymond W. , Post, Robert M, Ostacher, Michael J. , Lafer, Beny , Cleare, Anthony J. , O’Donovan, Claire , Ortiz, Abigail, Henry, Chantal , Kanba, Shigenobu, Rosenblat, Joshua D. , Parikh, Sagar V. , Bond, David J. , Goldberg, Joseph F. , Orum, Margo, Osser, David N. , Frye, Mark A. , Manicavasagar, Vijaya , Carlson, Gabrielle A. , Malhi, Gin S. , Fountoulakis, Konstantinos Ν. , Vieta, E , Grunze, Heinz , Bond, David J , Hajek, Tomas , Alda, Martin , Fountoulakis, Konstantinos N , Yatham, Lakshmi N , Young, Allan H , Cleare, Anthony J , Berk, Michael , Ortiz, Abigail , Parker, Gordon Barraclough , MacQUEEN, GLENDA M. , Sajatovic, Martha , Zimmerman, Mark A. , Fountoulakis, Kostas N, Calkin, Cynthia , Anand, Amit , Rybakowski, Janusz K , Bora, Emre , Post, Robert M, Burdick, Katherine E. , Grunebaum, Michael F. , Frangou, Sophia , McIntyre, Roger S. , Fagiolini, Andrea , Swartz, Holly A , Kessing, L V , Malhi, Gin S , Ostacher, Michael J

Mayo Clinic

Australian & New Zealand Journal of Psychiatry | October 31, 2018 | Volume: 52 | Issue: 12 | Pages: 1173-1182

10.1177/0004867418808382 | PMID 30378461 Get It

Objective: To derive new criteria sets for defining manic and hypomanic episodes (and thus for defining the bipolar I and II disorders), an international Task Force was assembled and termed AREDOC reflecting its role of Assessment, Revision and Evaluation of DSM and other Operational Criteria. This paper reports on the first phase of its deliberations and interim criteria recommendations. Method: The first stage of the process consisted of reviewing Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, and recent International Classification of Diseases criteria, identifying their limitations and generating modified criteria sets for further in-depth consideration. Task Force members responded to recommendations for modifying criteria and from these the most problematic issues were identified. Results: Principal issues focussed on by Task Force members were how best to differentiate mania and hypomania, how to judge ‘impairment’ (both in and of itself and allowing that functioning may sometimes improve during hypomanic episodes) and concern that rejecting some criteria (e.g. an imposed duration period) might risk false-positive diagnoses of the bipolar disorders. Conclusion: This first-stage report summarises the clinical opinions of international experts in the diagnosis and management of the bipolar disorders, allowing readers to contemplate diagnostic parameters that may influence their clinical decisions. The findings meaningfully inform subsequent Task Force stages (involving a further commentary stage followed by an empirical study) that are expected to generate improved symptom criteria for diagnosing the bipolar I and II disorders with greater precision and to clarify whether they differ dimensionally or categorically.
Management and Outcomes of Cardiac Sarcoidosis: A 20-Year Experience in Two Tertiary Care Centres
Fussner, Lynn A. , Karlstedt, Erin, Hodge, David O. , Kalra, Sanjay , Carmona, Eva M. , Utz, James P., Isaac, Debra , Cooper, Leslie T. , Carmona, Eva M , Cooper, Leslie T , Fine, Nowell Mark

Mayo Clinic

European Journal of Heart Failure | October 31, 2018 | Volume: 20 | Issue: 12 | Pages: 1713-1720

10.1002/ejhf.1319 | PMID 30378224 Get It

Abstract Aims Cardiac sarcoidosis (CS) often presents with ventricular arrhythmias, heart block, and cardiomyopathy. The prognosis of CS with contemporary management is uncertain. We estimated the impact of baseline and treatment variables on left ventricular ejection fraction (LVEF), ventricular assist device placement, heart transplant, and death. Methods and results We identified patients with CS seen from 1994–2014 at two large academic medical centres. All met the 2014 Heart Rhythm Society expert consensus criteria for diagnosis. From the 574 patients identified, 91 met inclusion criteria. Twenty-two (24.2%) were diagnosed by endomyocardial biopsy. Cardiomyopathy was the primary presentation in 47 patients (51.6%). Within 90 days of diagnosis, 41 patients (45.0%) received prednisone alone, 29 (31.9%) received alternative immunosuppression with or without prednisone, and 21 (23.1%) received no immunosuppression. During follow-up, 31 of 47 cardiomyopathy patients experienced improvement in LVEF, while 23 experienced decline in LVEF or clinical exacerbation, and 15 of 22 patients presenting with ventricular arrhythmia had recurrence. These results did not differ by treatment group. During a median follow-up of 44 months for our cohort, 14 patients reached the composite endpoint of ventricular assist device placement, heart transplant, or death. Survival without the composite outcome did not differ by treatment group, but was worse among patients presenting with cardiomyopathy (log-rank = 0.005). Conclusion In a large series of CS subjects, rates of ventricular arrhythmia and heart failure events remain high with no treatment regimen clearly associated with better outcome. Patients with cardiomyopathy at diagnosis were more likely to reach the composite endpoint.
Liquid Biopsy in Gastrointestinal Cancers
Saini, Aman , Albadawi, Hassan , Kuo, Malia, Alzubaidi, Sadeer , Naidu, Sailendra , Knuttinen, M. Grace , Öklü, Rahmi , Pershad, Yash , Oklu, Rahmi

Mayo Clinic

Diagnostics | October 31, 2018 | Volume: 8 | Issue: 4 | Pages: 75

10.3390/diagnostics8040075 | PMID 30380690 Get It

Liquid biopsy is the sampling of any biological fluid in an effort to enrich and analyze a tumor’s genetic material. Peripheral blood remains the most studied liquid biopsy material, with circulating tumor cells (CTC’s) and circulating tumor DNA (ctDNA) allowing the examination and longitudinal monitoring of a tumors genetic landscape. With applications in cancer screening, prognostic stratification, therapy selection and disease surveillance, liquid biopsy represents an exciting new paradigm in the field of cancer diagnostics and offers a less invasive and more comprehensive alternative to conventional tissue biopsy. Here, we examine liquid biopsies in gastrointestinal cancers, specifically colorectal, gastric, and pancreatic cancers, with an emphasis on applications in diagnostics, prognostics and therapeutics.
Individual differences in ERP measures of executive function in early childhood: Relation to low-risk preterm birth and parent-reported behavior
Hodel, Amanda S. , Hunt, Ruskin H., Heuvel, Sara E. Van Den, Wiltgen, Anika, Thomas, Kathleen M. , Brumbaugh, Jane E.

Mayo Clinic

Child Neuropsychology | October 31, 2018 | Volume: 25 | Issue: 7 | Pages: 914-942

10.1080/09297049.2018.1540690 | PMID 30376759 Get It

Chemical pharmacotherapy for the treatment of orthostatic hypotension
Cheshire, William P. , Cheshire, William P

Mayo Clinic

Expert Opinion on Pharmacotherapy | October 31, 2018 | Volume: 20 | Issue: 2 | Pages: 187-199

10.1080/14656566.2018.1543404 | PMID 30376728 Get It

A Bundled Payment Model for Pediatric Distal Radius Fractures: Defining an Episode of Care
Godfrey, Jenna , Cornwall, Roger , Sitzman, Thomas J. , Little, Kevin J.

Mayo Clinic

Journal of Pediatric Orthopaedics | October 30, 2018 | Volume: 39 | Issue: 3 | Pages: e216-e221

10.1097/bpo.0000000000001286 | PMID 30376495 Get It

Background: Distal radius fractures are the most common fracture of childhood, occurring in ∼1 per 100 children annually. Given the high incidence of these fractures, we explored feasibility of a bundled payment model. We determined the total treatment costs for each child and identified components of fracture management that contributed to variations in cost. Methods: We retrospectively reviewed all hospital and physician costs related to the treatment of closed distal radius fractures at a large academic children’s hospital. We included all children age 2 to 15 years treated by an orthopaedic surgeon for an isolated closed distal radius fracture between 2013 and 2015. We compared total treatment costs by fracture management approach. We then estimated the contribution of each component of fracture management to total treatment costs using linear regression. Results: We identified 5640 children meeting the inclusion criteria, of which 4602 (81.6%) received closed treatment without manipulation, 922 (16.3%) underwent closed reduction in the clinic, emergency department, or radiology procedure suite, and 116 (2.1%) underwent treatment in the operating room. The median cost for closed treatment without manipulation was $1390 [interquartile range (IQR) 1029 to 1801], compared with $4263 (IQR, 3740 to 4832) for closed reduction and $9389 (IQR, 8272 to 11,119) for closed reduction and percutaneous pinning (P<0.001). In multivariable regression analysis, fracture management approach and use of the operating room environment were the largest cost drivers (P<0.001, R 2=0.88). Closed reduction in the clinic or emergency department added $894 (95% confidence interval, 819-969) to treatment costs, while closed reduction in the operating room added $5568 (95% confidence interval, 5224-6297). Location of the initial clinical evaluation, number of radiographic imaging series obtained, and number of orthopaedic clinic visits also contributed to total costs. Conclusions: Closed pediatric distal radius fractures treated without manipulation show small variations in treatment costs, making them well suited for bundled payment. Bundled payments for these fractures could reduce costs by encouraging adoption of existing evidence-based practices. Level of Evidence: Level III—therapeutic.
CORR Insights®: Do Spatiotemporal Gait Parameters Improve After Pilon Fracture in Patients Who Use the Intrepid Dynamic Exoskeletal Orthosis?
Kaufman, Kenton R.

Mayo Clinic

Clinical Orthopaedics & Related Research | October 30, 2018 | Volume: 477 | Issue: 4 | Pages: 848-849

10.1097/corr.0000000000000543 | PMID 30376461 Get It